Lin Yan
29Patents
6h-index
54Co-inventors
72Inventor score
Filing activity: Mar 21, 1997 → Jun 1, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7005436B2 | Heterocyclo inhibitors of potassium channel function | Chemistry; Metallurgy | 114 | Expired |
| US7157451B2 | Heterocyclic dihydropyrimidine compounds | Human Necessities | 59 | Expired |
| US6706720B2 | Heterocyclic dihydropyrimidine compounds | Human Necessities | 29 | Expired |
| US7202253B2 | Cycloalkyl inhibitors of potassium channel function | Chemistry; Metallurgy | 22 | Expired |
| US7605171B2 | (3,4-disubstituted)propanoic carboxylates as S1P (Edg) receptor agonists | Chemistry; Metallurgy | 20 | Expired |
| US7999107B2 | Substituted pyrano[2,3-B]pyridine derivatives as cannabinoid-1 receptor modulators | Chemistry; Metallurgy | 8 | Active |
| US9427475B2 | Glucose-responsive insulin conjugates | Chemistry; Metallurgy | 4 | Active |
| US10017556B2 | Insulin receptor partial agonists | Chemistry; Metallurgy | 3 | Active |
| US6040433A | Sulfinyl hexose derivatives useful for glycosylation | Chemistry; Metallurgy | 3 | Expired |
| US7582654B2 | Heterocyclo inhibitors of potassium channel function | Chemistry; Metallurgy | 1 | Active |
| US10689430B2 | Insulin receptor partial agonists | Chemistry; Metallurgy | 1 | Active |
| US8361994B2 | Primary amine diazeniumdiolate heterocyclic derivatives | Chemistry; Metallurgy | 1 | Active |
| US8119806B2 | Cicletanine derivatives | Chemistry; Metallurgy | 1 | Active |
| US8648058B2 | Diazeniumdiolate cyclopentyl derivatives | Chemistry; Metallurgy | 1 | Active |
| US10183981B2 | Insulin receptor partial agonists | Chemistry; Metallurgy | 1 | Active |
| US7541362B2 | Heterocyclic dihydropyrimidine compounds | Human Necessities | 1 | Active |
| US11041009B2 | Glucose responsive insulin comprising a tri-valent sugar cluster for treatment of diabetes | Human Necessities | 1 | Active |
| US8623846B2 | Diazeniumdiolate cyclohexyl derivatives | Chemistry; Metallurgy | 1 | Active |
| US11820805B2 | Conjugate based systems for controlled insulin delivery | Human Necessities | 0 | Active |
| US10800827B2 | Insulin receptor partial agonists | Chemistry; Metallurgy | 0 | Active |
| US11058775B2 | Insulin dimer-incretin conjugates | Human Necessities | 0 | Active |
| US7659294B2 | 2-(aryl)azacyclylmethyl carboxylates, sulfonates, phosphonates, phosphinates and heterocycles as S1P receptor agonists | Chemistry; Metallurgy | 0 | Active |
| US9889205B2 | Glucose-responsive insulin conjugates | Chemistry; Metallurgy | 0 | Active |
| US12427187B2 | Glucose-responsive insulin conjugates | Chemistry; Metallurgy | 0 | Active |
| US8354394B2 | Diuretics | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.